A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

INTRODUCTION AND HYPOTHESIS: The objective of this study was to assess the tolerability and treatment preference in patients with overactive bladder (OAB) treated with mirabegron or tolterodine. METHODS: This was a two-period, 8-week crossover, double-blind, phase IV study (PREFER; NCT02138747) in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Urogynecol J
Main Authors: Staskin, David, Herschorn, Sender, Fialkov, Jonathan, Tu, Le Mai, Walsh, Terry, Schermer, Carol R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780540/
https://ncbi.nlm.nih.gov/pubmed/28620791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00192-017-3377-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados